SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIBs price action and prolonged sideways consolidation are driving discussion, with some traders looking for a breakout while others complain of stagnation and expect further weakness. Bullish hopes for a broader meme-coin rally contrast with skepticism about the tokens utility and large supply.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

Financials are under pressure amid rising Treasury yields and concerns about bank activity, credit conditions, and the broader economy, with traders debating whether the sector is nearing an oversold bounce or has further downside. Upcoming results from major banks are a key focus, as investors look for signs that earnings can stabilize the sector.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Papua New Guinea, Australia, Ghana, Suriname, Argentina, Peru, Mexico, Canada, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is drawing attention amid a broader gold-miner trade, with traders citing golds safe-haven appeal and concerns about inflation, currency debasement and geopolitical risk. Some are bullish on a gold rebound, while others point to interest-rate and operating-cost pressures; speculation about a company-specific leak or contract remains unconfirmed.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroup is drawing attention ahead of its Q3 earnings, with traders weighing whether results and guidance can overcome pressure on bank stocks from rising yields and concerns about loan demand and credit quality. Some are positioning bullishly into the report, while others worry Citi could miss expectations or give a cautious outlook.

RTX Corp. is an aerospace and defense company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers. It operates through the following segments: Collins Aerospace Systems (Collins), Pratt and Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). The Collins segment manufactures and sells aero structures, avionics, interiors, mechanical systems, mission systems, and power controls. The Pratt and Whitney segment includes the design and manufacture of aircraft engines and auxiliary power systems for commercial, military, and business aircraft. The RIS segment is involved in the development of sensors, training, and cyber and software solutions. The RMD segment offers end-to-end solutions to detect, track, and engage threats. The company was founded in 1922 and is headquartered in Arlington, VA.

RTX Corp

Raytheon Technologies Corporation

Raytheons multiyear U.S. Navy contract for SM-3 interceptors is drawing attention as part of a broader push to replenish missile-defense inventories. Traders view the award as supportive of demand and backlog, but many are frustrated by RTXs weak share performance and flag uncertainty over congressional funding.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

A strong quarterly report and raised outlook, alongside optimism about Rhodes momentum and international expansion, are fueling discussion around e.l.f. Beautys rebound. Bulls see further growth potential, while skeptics point to the stocks sharp run-up, valuation, and rising marketing costs as reasons for caution or profit-taking.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick is drawing attention as traders position for higher gold and mining-sector earnings, citing inflation, government debt and currency-debasement concerns as support for precious metals. The community is broadly bullish on miners, while some debate whether Barricks planned North American IPO will unlock value or create execution and valuation risks.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is drawing attention ahead of its third-quarter earnings report, with traders weighing its higher annual outlook, analyst estimate changes and growth prospects against recent share-price weakness. Views are mixed: some expect the rally to continue, while others point to a pullback and question the stocks performance.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanley is drawing attention around its upcoming Q3 earnings as bank stocks have pulled back amid concerns about rising Treasury yields, deposit costs, and slower loan growth. Traders are divided between viewing the sector as oversold and a buying opportunity and expecting further weakness if rates continue to pressure financials.

SKY is a governance token, which is like a digital voting share, for Sky Protocol. This system launched in 2024 as a rebrand and upgrade of the older Maker Protocol. Sky Protocol’s main value lies in giving users a simple, secure way to trade, save, and earn rewards without ever giving up control of their funds. It is built around a stablecoin called USDS, which is always worth one US dollar, but it is completely decentralized.  The protocol is run by automated agreements called smart contracts, so there’s no middleman controlling users' money. The system uses two main tokens: USDS for stable savings, and SKY for community governance. users can help secure the network and earn rewards by staking their SKY tokens in the Staking Engine, which is like locking them in an interest-bearing account to help the system run. The protocol also uses SkyLink to seamlessly connect users' funds across different blockchains for faster and cheaper transactions.  The Sky Protocol is unique because it has no single CEO or traditional core team of investors; instead, it is managed entirely by its global community of SKY token holders. This decentralized setup means that SKY is primarily used for two core utilities: it grants essential voting power to decide on all major system changes, and it can be staked in the Staking Engine to help secure the network and earn rewards. Staking also provides holders with the ability to borrow the USDS stablecoin, making SKY the essential key for both governance and income generation within the ecosystem.

Skycoin

Galaxy Digitals adoption of Skys yield-bearing sUSDS as a treasury asset and institutional collateral, along with its reported SKY token purchase, is fueling bullish attention and breakout talk. Traders are also debating whether the move has staying power, with skeptics warning of a speculative pump and raising concerns about SDEVs dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nifty Pharma sinks as Trump readies 100% drug tariffs

… more than 5%. Glenmark Pharmaceuticals , Aurobindo Pharma , Sun Pharmaceutical Industries, and Ipca Laboratories … to 50% of all generic drugs consumed in the US, making the … with the White House. For Indian pharmaceutical companies, the stakes remain high. …

Brief India: HDFC Bank (HDFCB IN) Tactical Outlook: Hold or Sell? and more

In this briefing: HDFC Bank (HDFCB IN) Tactical Outlook: Hold or Sell? Infosys: The AI-First Services Opportunity- Capturing a $400 Billion Market Exencial Indutry Tiding Aequitas: Indo-MIM Pre-IPO - The Positives - Global-Scale Manufacturing Platform HSIE Results Daily: IPCA Laboratories, IRB Infra, Galaxy Surfactants, Ahluwalia Contracts 1. HDFC Bank (HDFCB IN) Tactical Outlook: Hold or Sell? HDFC Bank (HDFCB IN) has been losing steam since last summer. In the last few months the stock started to sell-off, but it did not lose more than 10%. A recent pullback was flagged as oversold by our quantitative model, last Friday. Then the stock started to rally this week. We think the current rally may be a sell opportunity, possibly taking advantage of the stock recent volatility. Selling setups identified by our model are discussed in this insight. 2. Infosys: The AI-First Services Opportunity- Capturing a $400 Billion Market The shift to "Agentic AI" could propel the global economy to $500 trillion , provided companies overhaul business architectures to bridge the current gap between tech progress and realized value.

Brief India: Infosys: The AI-First Services Opportunity- Capturing a $400 Billion Market and more

In this briefing: Infosys: The AI-First Services Opportunity- Capturing a $400 Billion Market Exencial Indutry Tiding Aequitas: Indo-MIM Pre-IPO - The Positives - Global-Scale Manufacturing Platform HSIE Results Daily: IPCA Laboratories, IRB Infra, Galaxy Surfactants, Ahluwalia Contracts SignatureGlobal India Ltd - SignatureGlobal’s Leap into Commercial Real Estate 1. Infosys: The AI-First Services Opportunity- Capturing a $400 Billion Market The shift to "Agentic AI" could propel the global economy to $500 trillion , provided companies overhaul business architectures to bridge the current gap between tech progress and realized value. Through the Topaz Fabric , Infosys is deploying over 600 specialized agents and small language models (SLMs) to help 90% of their top clients move from pilots to production. Success requires navigating the " Brownfield " productivity gap, where legacy systems and data silos currently consume 60-80% of IT budgets , hindering the deployment of high-impact AI solutions. 2.

Brief India: Exencial Indutry Tiding and more

In this briefing: Exencial Indutry Tiding Aequitas: Indo-MIM Pre-IPO - The Positives - Global-Scale Manufacturing Platform HSIE Results Daily: IPCA Laboratories, IRB Infra, Galaxy Surfactants, Ahluwalia Contracts SignatureGlobal India Ltd - SignatureGlobal’s Leap into Commercial Real Estate Axis PUNCH: Greenply Industries Ltd - 17th February, 2026 1. Exencial Indutry Tiding Bajaj Hindusthan Sugar's sales decline by 6.7% in December 2025 quarter Man-Made filaments & fibres industry's sales grow by 15.2% in December 2025 quarter Personal & home care products industry's sales grow by 5.4% in December 2025 quarter 2. Aequitas: Indo-MIM Pre-IPO - The Positives - Global-Scale Manufacturing Platform Indo-MIM Ltd (1666551D IN) (IML) is looking to raise about US$750m in its upcoming India IPO. IML provides end-to-end solutions for the manufacture of precision engineering components using metal injection molding technology. Its capabilities include mold designing and tooling, coupled with finishing and assembly operations.

Brief Growth Ideas: Primer: CSL (CSL AT) - Feb 2026 and more

In this briefing: Primer: CSL (CSL AT) - Feb 2026 Aequitas: Indo-MIM Pre-IPO - The Positives - Global-Scale Manufacturing Platform Primer: Shenzhen Vmax New Energy Lt (688612 CH) - Feb 2026 Oil futures: Crude lower as Iran says 'understanding' reached with US HSIE Results Daily: IPCA Laboratories, IRB Infra, Galaxy Surfactants, Ahluwalia Contracts 1. Primer: CSL (CSL AT) - Feb 2026 CSL is a global biotechnology leader with a dominant position in plasma-derived therapies ( CSL Behring) and a significant presence in the influenza vaccine market ( CSL Seqirus). The recent acquisition of Vifor Pharma has diversified CSL's portfolio into the attractive markets of nephrology and iron deficiency, providing a new avenue for growth. While facing near-term headwinds from policy changes, competitive pressures, and a recent CEO transition, the company's long-term outlook is supported by a strong R&D pipeline, recovering plasma collections, and strategic cost-saving initiatives. This content is AI-generated and displayed for general informational purposes only.

Brief India: Aequitas: Indo-MIM Pre-IPO - The Positives - Global-Scale Manufacturing Platform and more

In this briefing: Aequitas: Indo-MIM Pre-IPO - The Positives - Global-Scale Manufacturing Platform HSIE Results Daily: IPCA Laboratories, IRB Infra, Galaxy Surfactants, Ahluwalia Contracts SignatureGlobal India Ltd - SignatureGlobal’s Leap into Commercial Real Estate Axis PUNCH: Greenply Industries Ltd - 17th February, 2026 Ahluwalia Contracts India Ltd - Misses Estimates on Slower Execution; Retain BUY 1. Aequitas: Indo-MIM Pre-IPO - The Positives - Global-Scale Manufacturing Platform Indo-MIM Ltd (1666551D IN) (IML) is looking to raise about US$750m in its upcoming India IPO. IML provides end-to-end solutions for the manufacture of precision engineering components using metal injection molding technology. Its capabilities include mold designing and tooling, coupled with finishing and assembly operations. In this note, we talk about the positive aspects about the company’s historical performance. 2. HSIE Results Daily: IPCA Laboratories, IRB Infra, Galaxy Surfactants, Ahluwalia Contracts IPCA Laboratories: EBITDA growth of 22% YoY was driven by 7% YoY sales growth (India grew 12% YoY), higher GM (+226 bps YoY at 72.5%), and cost controls (staff/SG&A +10%/+4% YoY), causing the margin to expand to 22.7% (+284 bps YoY) IPCA expects (1) overall business to see 10-11% growth in the near term (IPCA standalone growth at 10-12% and Unichem business at 8-9%) (2) India business to outperform IPM growth in the next few years, led by sustained momentum in key therapies (pain, CVS, anti-diabetics, CNS, and derma), looking to in-licensing Semaglutide to participate in India GLP-1 market Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief Growth Ideas: Aequitas: Indo-MIM Pre-IPO - The Positives - Global-Scale Manufacturing Platform and more

In this briefing: Aequitas: Indo-MIM Pre-IPO - The Positives - Global-Scale Manufacturing Platform Primer: Shenzhen Vmax New Energy Lt (688612 CH) - Feb 2026 Oil futures: Crude lower as Iran says 'understanding' reached with US HSIE Results Daily: IPCA Laboratories, IRB Infra, Galaxy Surfactants, Ahluwalia Contracts Pre-IPO Good Doctor Cloud Healthcare & Technology Group - Pain Points of Business Models and Outlook 1. Aequitas: Indo-MIM Pre-IPO - The Positives - Global-Scale Manufacturing Platform Indo-MIM Ltd (1666551D IN) (IML) is looking to raise about US$750m in its upcoming India IPO. IML provides end-to-end solutions for the manufacture of precision engineering components using metal injection molding technology. Its capabilities include mold designing and tooling, coupled with finishing and assembly operations. In this note, we talk about the positive aspects about the company’s historical performance. 2. Primer: Shenzhen Vmax New Energy Lt (688612 CH) - Feb 2026 Shenzhen Vmax New Energy Lt is a key supplier of power electronics for new energy vehicles (NEVs), specializing in on-board chargers and DC/DC converters.

Brief Growth Ideas: Primer: Shenzhen Vmax New Energy Lt (688612 CH) - Feb 2026 and more

In this briefing: Primer: Shenzhen Vmax New Energy Lt (688612 CH) - Feb 2026 Oil futures: Crude lower as Iran says 'understanding' reached with US HSIE Results Daily: IPCA Laboratories, IRB Infra, Galaxy Surfactants, Ahluwalia Contracts Pre-IPO Good Doctor Cloud Healthcare & Technology Group - Pain Points of Business Models and Outlook SignatureGlobal India Ltd - SignatureGlobal’s Leap into Commercial Real Estate 1. Primer: Shenzhen Vmax New Energy Lt (688612 CH) - Feb 2026 Shenzhen Vmax New Energy Lt is a key supplier of power electronics for new energy vehicles (NEVs), specializing in on-board chargers and DC/DC converters. The company is well-positioned to benefit from the continued growth of the global NEV market, particularly in China, its primary market. Financial performance has shown strong revenue growth, though profitability metrics warrant monitoring amidst a competitive landscape. This content is AI-generated and displayed for general informational purposes only. Please verify independently before use. 2.

Brief India: HSIE Results Daily: IPCA Laboratories, IRB Infra, Galaxy Surfactants, Ahluwalia Contracts and more

In this briefing: HSIE Results Daily: IPCA Laboratories, IRB Infra, Galaxy Surfactants, Ahluwalia Contracts SignatureGlobal India Ltd - SignatureGlobal’s Leap into Commercial Real Estate Axis PUNCH: Greenply Industries Ltd - 17th February, 2026 Ahluwalia Contracts India Ltd - Misses Estimates on Slower Execution; Retain BUY Fortis Healthcare Ltd - Healthy Core Performance; Expansion to Drive Next Leg 1. HSIE Results Daily: IPCA Laboratories, IRB Infra, Galaxy Surfactants, Ahluwalia Contracts IPCA Laboratories: EBITDA growth of 22% YoY was driven by 7% YoY sales growth (India grew 12% YoY), higher GM (+226 bps YoY at 72.5%), and cost controls (staff/SG&A +10%/+4% YoY), causing the margin to expand to 22.7% (+284 bps YoY) IPCA expects (1) overall business to see 10-11% growth in the near term (IPCA standalone growth at 10-12% and Unichem business at 8-9%) (2) India business to outperform IPM growth in the next few years, led by sustained momentum in key therapies (pain, CVS, anti-diabetics, CNS, and derma), looking to in-licensing Semaglutide to participate in India GLP-1 market Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Smartkarma | HSIE Results Daily: IPCA Laboratories, IRB Infra, Galaxy Surfactants, Ahluwalia Contracts

» Smartkarma / by HDFC Securities / Thematic (Sector/Industry) IPCA Laboratories: EBITDA growth of 22% YoY was driven by 7% YoY sales growth (India grew 12% YoY), higher GM (+226 bps YoY at 72.5%), and cost controls (staff/SG&A +10%/+4% YoY), causing the margin to expand to 22.7% (+284 bps YoY) IPCA expects (1) overall business to see 10-11% growth in the near term (IPCA standalone growth at 10-12% and Unichem business at 8-9%) (2) India business to outperform IPM growth in the next few years, led by sustained momentum in key therapies (pain, CVS, anti-diabetics, CNS, and derma), looking to in-licensing Semaglutide to participate in India GLP-1 market Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below. » Get straight to the source on Smartkarma.

Ipca Laboratories Ltd. engages in the manufacturing, marketing, research, and development of pharmaceutical products. Its products include Hydroxychloroquine Sulphate, Artemether and Lumefantrine and Acceclofenac and its combinations. The company was founded on October 19, 1949 and is headquartered in Mumbai, India.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	16.05	--	--	N/A
Q1 '26	12.16	15.84	30.25%	BEAT
Q4 '25	10.07	--	--	N/A
Q3 '25	11.66	--	--	N/A
Q2 '25	10.72	13.05	21.74%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

IPCALAB.NSE Earnings

Upcoming Earnings: Q2 '26

Historical Earnings